Back
Delek Logistics Partners LP Vs. Neurocrine Biosciences, Inc. Industry Stock Comparison
Buy
72
DKL
Delek Logistics Partners LP
Last Price:
$46.53
Seasonality Move:
0.25%
Buy
58
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$140.60
Seasonality Move:
3.52%
Buy
72
Delek Logistics Partners LP (DKL)
is a Buy
Is Delek Logistics Partners LP a Buy, Sell or Hold?
-
The current Delek Logistics Partners LP [DKL] share price is $45.71. The Score for DKL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
DKL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy, Sell or Hold?
-
The current Neurocrine Biosciences, Inc. [NBIX] share price is $137.35. The Score for NBIX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DKL Stock Price Chart
What is Delek Logistics Partners LP's stock price today?
-
The Delek Logistics Partners LP share price today is $45.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DKL is experiencing selling pressure, which indicates risk of future bearish movement.
NBIX Stock Price Chart
What is Neurocrine Biosciences, Inc.'s stock price today?
-
The Neurocrine Biosciences, Inc. share price today is $137.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight buying pressure.
DKL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 51.74 | Buy |
| Chaikin Money Flow: | -131154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.43 - 46.15) | Buy |
| Bollinger Bands (100): | (43.74 - 45.7) | Buy |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.49 | Sell |
| Relative Strength Index (14 RSI): | 35.39 | Sell |
| Chaikin Money Flow: | 95367 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (141.83 - 153.93) | Sell |
| Bollinger Bands (100): | (137.02 - 149.04) | Sell |
DKL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.43 | Buy |
| 20-day SMA: | 45.11 | Buy |
| 50-day SMA: | 45.21 | Buy |
| 200-day SMA: | 43.31 | Buy |
| 8-day EMA: | 45.57 | Buy |
| 20-day EMA: | 45.29 | Buy |
| 50-day EMA: | 45.1 | Buy |
| 200-day EMA: | 43.82 | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 141.57 | Sell |
| 20-day SMA: | 146.59 | Sell |
| 50-day SMA: | 146.51 | Sell |
| 200-day SMA: | 131.32 | Buy |
| 8-day EMA: | 140.83 | Sell |
| 20-day EMA: | 144.26 | Sell |
| 50-day EMA: | 144.98 | Sell |
| 200-day EMA: | 136.72 | Buy |
Delek Logistics Partners LP Earnings Growth & DKL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.69 per share, and a decrease next year of $0.00 per share.
Neurocrine Biosciences, Inc. Earnings Growth & NBIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.26 per share, and an increase next year of $1.51 per share.
Delek Logistics Partners LP Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||